Jaguar Animal Health
Price & Volume
Stats
See more52W Range | $0.72-$85.40 |
Market Cap | $4.7M |
Shares Short | 87,153 |
Financials
See moreRevenue (12 Mos) | $27.8M |
Revenue Growth (YoY) | -58.9% |
Gross Profit (12 Mos) | $22.8M |
Diluted EPS | -$739.43 |
News
See moreYahoo Finance • 17 hours ago
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Yahoo Finance • 7 days ago
Jaguar Health targets mid-2027 MVID NDA filing with possible end-2027 U.S. approval, backed by up to 48% parenteral support reductions
Yahoo Finance • 30 days ago
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Yahoo Finance • 2 months ago
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
About
CEO | Ms. Lisa A. Conte |
CFO | Ms. Carol R. Lizak M.B.A. |
Address | 200 Pine Street, San Francisco, CA, United States, 94104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 47 |